Friday, September 9, 2016 | 12:00 PM - 4:00 PM
Speakers: Shohei Koide (NYU Langone Medical Center), Jonathan R. Lai (Albert Einstein College of Medicine), Jim Wells (University of California San Francisco), and Manoj Charati (Pfizer)
This symposium will highlight state-of-the-art technologies in protein and antibody engineering, and antibody-drug conjugates. The implementation of these methods to specific diseases, and unique research tools, will also be discussed.
Friday, September 16, 2016 | 8:30 AM - 6:00 PM
Speakers: Lori B. Andrews (Illinois Institute of Technology), Gary Bennett (Duke University), Barbara Millen (Healthmain), Tooraj Mirshahi (Geisinger Clinic), Satchidananda Panda (SALK Institute), Ruth E. Patterson (University of California San Diego), Michael Price (Georgia State University), Karandeep Singh (University of Michigan), and Nicholas Tatonetti (Columbia University)
Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?
September 21 - 23, 2016
Featuring: Peder Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)
Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.
Tuesday, October 25, 2016 | 9:00 AM - 5:00 PM
Speakers: Marcus Bantscheff (Cellzome/GSK), Benjamin F Cravatt (The Scripps Research Institute), Craig Crews (Yale University), Howard Hang (The Rockefeller University), Ruth Nussinov (National Cancer Institute), Brian Raymer (Pfizer), Bryan Roth (University of North Carolina), Eranthie Weerapana (Boston College)
Chemical Biology is changing the face of drug discovery. This symposium will highlight recent developments in the field, featuring examples from neurobiology and cancer, the ubiquitin proteasome system, GPCRs, and protein lipidation.
Wednesday, November 9, 2016 | 8:30 AM - 5:15 PM
Keynote Speaker: Lawrence Mayer (Celator Pharmaceuticals)
Explore approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and compare biological and non-biological complex drug families.
Wednesday, July 13, 2016 | 9:00 AM - 5:00 PM
Keynote Speaker: David Bartel (Whitehead/MIT/HHMI)
Speakers: Paul Grint (Regulus Therapeutics), David S Hong (The University of Texas MD Anderson Cancer Center ), Daniel J Siegwart (University of Texas Southwestern Medical Center), Frank Slack (BIDMC Cancer Center/Harvard Medical School), James W Welsh (The University of Texas MD Anderson Cancer Center)
miRNAs play critical roles in regulating gene expression. This symposium will present up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.
Wednesday, June 29, 2016 | 7:00 PM - 8:30 PM
Featuring: Daniel Harlow (Harvard University Center for the Fundamental Laws of Nature), Scott Aaronson (Massachusetts Institute of Technology), and Brian Swingle (Stanford Institute for Theoretical Physics)
Moderator: George Musser (Spooky Action at a Distance)
Recent research suggests that quantum information and entanglement of quantum states—a term coined by Schrödinger to describe "spooky action at a distance" between quantum particles in his letters to Einstein in which he also proposed his famous thought experiment, Schrödinger's cat, to illustrate quantum superposition—may be key to understanding quantum gravity, one of the greatest unsolved problems of modern physics. Physicists are now wrestling with another paradox thought experiment that describes the fate of quantum states at the event horizon of a black hole and may upend some of the time-tested fundamental theories. This panel will discuss the fascinating interplay between two great theories of the 20th century—quantum theory and general relativity—and how these phenomena may be exploited, from black holes to quantum computing.
Monday, June 13, 2016 | 7:00 PM - 8:30 PM
Featuring: Adam Frank (University of Rochester), Louisa Preston (astrobiologist and author), Jason Thomas Wright (Pennsylvania State University), and Stephen M. Gardiner (University of Washington)
Moderator: Ira Flatow (PRI's Science Friday®)
The Fermi Paradox—the apparent contradiction between the high probability of the existence of extraterrestrial civilizations and the lack of contact with such civilizations—continues to captivate our minds. Join our panel of leading physicists and philosophers as they explore the question: "Where is everybody?" as well as other questions: How does scientific knowledge direct our future scientific and technological pursuits on Earth and in space? How does science inform human ethics? Does science make us better citizens of the universe?
Monday, June 13, 2016 | 10:00 AM - 3:30 PM
Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)
This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.
Edited by Jeffrey D. Laskin
(Rutgers University School of Public Health)
Chemical threats, both accidental and deliberate, are of critical concern globally. This, the first of two Annals issues devoted to this topic, presents 23 papers that discuss various countermeasures against chemical threats.
Organizers: Glen de Vries (Medidata Solutions), John J. Mastrototaro (Medtronic), Bernard Munos (FasterCures), Fiorenzo Omenetto (Tufts University), Leonard Sacks (U.S. Food and Drug Administration), Melanie Brickman Stynes (The New York Academy of Sciences), Brooke Grindlinger (The New York Academy of Sciences), and Daniel Radiloff (The New York Academy of Sciences)
This eBriefing considers the use of data from wearable sensors and mobile devices in medical care and clinical trials and looks at security and regulatory issues for health data.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents papers from a three-part series, in collaboration with the Nour Foundation, on the relevance of modern-day physics to perennial questions confronting human existence.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents discussions ofnutrition and the science of disease prevention; designing optogenetically controlled RNA for regulating biological systems; and how ion channels sense mechanical force